CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,023,010
- in 6 filings, $3.0M under 10b5-1 plans
Net −$3,023,010. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Barrow Robert −$1.9M Chief Executive Officer sold 2% of stake
- Sullivan Mark −$514K Chief Legal Officer sold 3% of stake
- Karlin Daniel −$397K Chief Medical Officer sold 1% of stake
- Roberts Brandi −$123K Chief Financial Officer sold <1% of stake
- Wiley Matthew T. −$113K Chief Commercial Officer sold <1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-25 | Sullivan Mark Chief Legal Officer | Sale 10b5-1 | −14,051 | $36.57 | $514K | 494,228 |
| 2026-09-14 | Sullivan Mark Chief Legal Officer | Grant or award | +125,000 | 508,279 | ||
| 2026-08-12 | Sullivan Mark Chief Legal Officer | Grant or award | +62,500 | 383,071 | ||
| 2026-06-25 | Sullivan Mark Chief Legal Officer | Sale 10b5-1 | −13,008 | $45.03 | $586K | 320,571 |
| 2026-06-22 | Sullivan Mark Chief Legal Officer | Grant or award | +62,500 | 333,579 | ||
| 2026-03-25 | Sullivan Mark Chief Legal Officer | Sale 10b5-1 | −10,702 | $18.47 | $198K | 271,079 |
| 2026-02-03 | Sullivan Mark Chief Legal Officer | Grant or award | +125,000 | 407,576 | ||
| 2025-12-26 | Sullivan Mark Chief Legal Officer | Sale 10b5-1 | −11,276 | $13.15 | $148K | 282,576 |
| 2025-09-25 | Sullivan Mark Chief Legal Officer | Sale 10b5-1 | −11,278 | $9.77 | $110K | 293,852 |
| 2025-06-25 | Sullivan Mark Chief Legal Officer | Sale 10b5-1 | −11,491 | $6.80 | $78K | 305,130 |
| 2025-03-25 | Sullivan Mark Chief Legal Officer | Sale 10b5-1 | −6,576 | $6.74 | $44K | 316,621 |
| 2025-03-12 | Sullivan Mark Chief Legal Officer | Grant or award | +150,000 | 323,197 | ||
| 2024-12-26 | Sullivan Mark Chief Legal Officer | Sale 10b5-1 | −4,519 | $7.43 | $34K | 173,197 |
| 2024-09-25 | Sullivan Mark Chief Legal Officer | Sale 10b5-1 | −4,430 | $5.98 | $26K | 177,716 |
| 2024-06-25 | Sullivan Mark Chief Legal Officer | Sale 10b5-1 | −17,854 | $7.22 | $129K | 182,146 |
| 2024-02-27 | Sullivan Mark Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2023-04-13 | Sullivan Mark Chief Legal Officer | Grant or award | +200,000 | 200,000 |
Page 1 of 1 · 17 trades